Mycosis Fungoides / Sézary Syndrome · line 1 · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Line of therapy	1
Track	local_therapy
Linked regimen	`None`

ID	`IND-MF-EARLY-1L-SKIN-DIRECTED`
Type	Indication
Status	reviewed 2026-04-25 \| pending_clinical_signoff
Diseases	`DIS-MF-SEZARY`
Sources	`SRC-NCCN-BCELL-2025`

Notes

STUB. Skin-directed no-regimen track for early-stage MF; routes to systemic on B2/LCT triggers.

Used By

Algorithms

ALGO-MF-SEZARY-1L - ALGO-MF-SEZARY-1L

Indication

IND-PENILE-SCC-1L-ORGAN-SPARING - IND-PENILE-SCC-1L-ORGAN-SPARING
IND-PENILE-SCC-1L-PENECTOMY-NODAL - IND-PENILE-SCC-1L-PENECTOMY-NODAL